GRT 7019

Drug Profile

GRT 7019

Alternative Names: GRT-7019; Versatis LE

Latest Information Update: 01 Feb 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Grunenthal
  • Class Acetanilides; Analgesics; Non-opioid analgesics; Phenylacetates
  • Mechanism of Action Cyclooxygenase inhibitors; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Pain
  • Clinical Phase Unknown Back pain

Most Recent Events

  • 15 Jan 2018 Grunenthal completes a phase II trial in Pain in Austria (EudraCT2016-002611-18)
  • 10 May 2017 Clinical trials in Back pain in Germany (Topical) before May 2017 (Grunenthal Website; May 2017)
  • 27 Apr 2017 Phase-II clinical trials in Pain in Austria (Topical) (EudraCT2016-002611-18)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top